Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
| world_health_organization [2022/08/25 23:29] liam | world_health_organization [2023/07/04 22:17] (current) liam [Donors] | ||
|---|---|---|---|
| Line 15: | Line 15: | ||
| On May 5, 2014, Director-General [[Margaret Chan]] declared the international spread of [[polio]] a [[Public Health Emergency of International Concern]] (PHEIC). The PHEIC declaration has remained in effect as of the most recent emergency committee meeting in June 2022.((// | On May 5, 2014, Director-General [[Margaret Chan]] declared the international spread of [[polio]] a [[Public Health Emergency of International Concern]] (PHEIC). The PHEIC declaration has remained in effect as of the most recent emergency committee meeting in June 2022.((// | ||
| - | ===== Affiliations | + | In 2019, the WHO published a [[pandemic preparedness]] document titled " |
| + | |||
| + | === COVID-19 | ||
| + | |||
| + | On June 10, 2021, the WHO convened the [[2nd Global Consultation on SARS-CoV-2 Variants of Concern and their Impact on Public Health Interventions]].((// | ||
| + | |||
| + | In 2022, the WHO Regional Office for Europe published a document titled " | ||
| + | immunization programmes." | ||
| + | |||
| + | ===== Organization | ||
| ==== Funding ==== | ==== Funding ==== | ||
| Line 64: | Line 73: | ||
| * [[Australian Red Cross Blood Service]] (ARCBS) | * [[Australian Red Cross Blood Service]] (ARCBS) | ||
| * [[Australian Respiratory Council]] | * [[Australian Respiratory Council]] | ||
| - | * [[Bank of America | + | * [[Bank of Africa |
| * [[Barcelona Institute for Global Health]] | * [[Barcelona Institute for Global Health]] | ||
| * [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
| Line 86: | Line 95: | ||
| * [[CDC Foundation]] | * [[CDC Foundation]] | ||
| * [[Central European Initiative]] | * [[Central European Initiative]] | ||
| + | * [[Centre for Ageing Better]] | ||
| * [[Chemo Ibérica]] | * [[Chemo Ibérica]] | ||
| * [[Chiba University]] | * [[Chiba University]] | ||
| Line 120: | Line 130: | ||
| * [[European Commission]] | * [[European Commission]] | ||
| * [[European and Developing Countries Clinical Trials Partnership]] | * [[European and Developing Countries Clinical Trials Partnership]] | ||
| + | * [[European Health Management Association]] (EHMA) | ||
| * [[European Hearing Instrument Manufacturers Association]] (EHIMA) | * [[European Hearing Instrument Manufacturers Association]] (EHIMA) | ||
| * [[European Investment Bank]] | * [[European Investment Bank]] | ||
| Line 133: | Line 144: | ||
| * [[Fondation Botnar]] | * [[Fondation Botnar]] | ||
| * [[Fondation d' | * [[Fondation d' | ||
| - | * [[Fondation des Immeubles pour les Organisations | + | * [[Fondation des Immeubles pour les Organisations |
| * [[Fondation Mérieux]] | * [[Fondation Mérieux]] | ||
| * [[Food and Agriculture Organization]] (FAO) | * [[Food and Agriculture Organization]] (FAO) | ||
| Line 150: | Line 161: | ||
| * [[Global Disability Innovation Hub]] | * [[Global Disability Innovation Hub]] | ||
| * [[Global Fund]] | * [[Global Fund]] | ||
| + | * [[Global Health Workforce Alliance]] | ||
| * [[Gojo Industries]] | * [[Gojo Industries]] | ||
| * [[Google]] | * [[Google]] | ||
| Line 156: | Line 168: | ||
| * [[Grand Challenges Canada]] | * [[Grand Challenges Canada]] | ||
| * [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
| + | * [[Guangdong Provincial Institute of Public Health]] | ||
| * [[HackerOne]] | * [[HackerOne]] | ||
| * [[Harvard T.H. Chan School of Public Health]] | * [[Harvard T.H. Chan School of Public Health]] | ||
| Line 175: | Line 188: | ||
| * [[International AIDS Society]] (IAS) | * [[International AIDS Society]] (IAS) | ||
| * [[International Company for Medical Necessities]] | * [[International Company for Medical Necessities]] | ||
| - | * [[International | + | * [[International |
| * [[International Development Law Organization]] | * [[International Development Law Organization]] | ||
| * [[International Federation for Medical and Biological Engineering]] (IFMBE) | * [[International Federation for Medical and Biological Engineering]] (IFMBE) | ||
| Line 206: | Line 219: | ||
| * [[Kanazawa University]] | * [[Kanazawa University]] | ||
| * [[Kantar]] | * [[Kantar]] | ||
| + | * [[Karolinska Institute]] | ||
| * [[King Baudouin Foundation United States]] (KBFUS) | * [[King Baudouin Foundation United States]] (KBFUS) | ||
| * [[King' | * [[King' | ||
| Line 220: | Line 234: | ||
| * [[china: | * [[china: | ||
| * [[Mada - Assistive Technology Center Qatar]] | * [[Mada - Assistive Technology Center Qatar]] | ||
| + | * [[Madrilenian Health Service]] (SERMAS) | ||
| * [[Mahidol University]] | * [[Mahidol University]] | ||
| + | * [[March of Dimes Foundation]] | ||
| * [[Marius Nasta National Institute for Pneumology]] | * [[Marius Nasta National Institute for Pneumology]] | ||
| * [[McKinsey & Company]] | * [[McKinsey & Company]] | ||
| Line 234: | Line 250: | ||
| * [[National Hospital Organization Kurihama Medical and Addiction Center]] | * [[National Hospital Organization Kurihama Medical and Addiction Center]] | ||
| * [[National Philanthropic Trust]] | * [[National Philanthropic Trust]] | ||
| + | * [[National University of Ireland Galway]] | ||
| * [[National University of Singapore]] | * [[National University of Singapore]] | ||
| * [[New Sunshine Charity Foundation]] | * [[New Sunshine Charity Foundation]] | ||
| Line 240: | Line 257: | ||
| * [[Norwegian Institute of Public Health]] | * [[Norwegian Institute of Public Health]] | ||
| * [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
| + | * [[Oil Search Foundation]] | ||
| * [[OPEC Fund for International Development]] (OFID) | * [[OPEC Fund for International Development]] (OFID) | ||
| * [[Open Society Foundations]] | * [[Open Society Foundations]] | ||
| Line 245: | Line 263: | ||
| * [[Options Consultancy Services]] | * [[Options Consultancy Services]] | ||
| * [[Organisation for Economic Co-Operation and Development]] (OECD) | * [[Organisation for Economic Co-Operation and Development]] (OECD) | ||
| + | * [[Organisation for the Prevention of Blindness]] | ||
| * [[P&P Patents and Technologies]] | * [[P&P Patents and Technologies]] | ||
| * [[Pacific Islands Health Officers Association]] (PIHOA) | * [[Pacific Islands Health Officers Association]] (PIHOA) | ||
| * [[Palestine]] | * [[Palestine]] | ||
| * [[PandemicTech]] | * [[PandemicTech]] | ||
| + | * [[Partnership for Maternal, Newborn and Child Health]] | ||
| * [[PAS Center]] | * [[PAS Center]] | ||
| * [[PATH]] | * [[PATH]] | ||
| Line 258: | Line 278: | ||
| * [[Portuguese Institute of Sports and Youth]] (IPDJ) | * [[Portuguese Institute of Sports and Youth]] (IPDJ) | ||
| * [[Potsdam Institute for Climate Impact Research]] (PIK) | * [[Potsdam Institute for Climate Impact Research]] (PIK) | ||
| + | * [[President and Fellows of Harvard College]] | ||
| * [[PricewaterhouseCoopers]] | * [[PricewaterhouseCoopers]] | ||
| * [[Program for Appropriate Technology in Health]] (PATH) | * [[Program for Appropriate Technology in Health]] (PATH) | ||
| Line 263: | Line 284: | ||
| * [[medical_technology_companies: | * [[medical_technology_companies: | ||
| * [[Quadram Institute]] | * [[Quadram Institute]] | ||
| + | * [[RAND Corporation]] | ||
| + | * [[Reckitt Benckiser]] | ||
| * [[Regions for Health Network]] | * [[Regions for Health Network]] | ||
| * [[Rehabilitation International]] | * [[Rehabilitation International]] | ||
| Line 273: | Line 296: | ||
| * [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
| * [[Rockefeller Foundation]] | * [[Rockefeller Foundation]] | ||
| + | * [[Romanian Angel Appeal]] | ||
| * [[Rotary International]] | * [[Rotary International]] | ||
| * [[Rotary Japan]] | * [[Rotary Japan]] | ||
| + | * [[Royal Tropical Institute]] | ||
| * [[Sabin Vaccine Institute]] (SVI) | * [[Sabin Vaccine Institute]] (SVI) | ||
| * [[Safaricom Foundation]] | * [[Safaricom Foundation]] | ||
| Line 282: | Line 307: | ||
| * [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
| * [[Sasakawa Health Foundation]] | * [[Sasakawa Health Foundation]] | ||
| + | * [[Save the Children]] | ||
| * [[Save the Children UK]] | * [[Save the Children UK]] | ||
| * [[SC Johnson]] | * [[SC Johnson]] | ||
| Line 292: | Line 318: | ||
| * [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
| * [[Snyk]] | * [[Snyk]] | ||
| + | * [[South African Medical Research Council]] | ||
| * [[Southeast Asia Tobacco Control Alliance]] (SEATCA) | * [[Southeast Asia Tobacco Control Alliance]] (SEATCA) | ||
| * [[Southern African Development Community]] (SADC) Secretariat | * [[Southern African Development Community]] (SADC) Secretariat | ||
| Line 306: | Line 333: | ||
| * [[Thai Health Promotion Foundation]] | * [[Thai Health Promotion Foundation]] | ||
| * [[TikTok]] | * [[TikTok]] | ||
| + | * [[True Colours Trust]] (TCT) | ||
| * [[Trustees of Columbia University in the City of New York]] | * [[Trustees of Columbia University in the City of New York]] | ||
| * [[Twitter]] | * [[Twitter]] | ||
| Line 312: | Line 340: | ||
| * [[UNFCU Foundation]] | * [[UNFCU Foundation]] | ||
| * [[UNICEF]] | * [[UNICEF]] | ||
| + | * [[UNICEF USA]] | ||
| * [[Union Nationale des Caisses d' | * [[Union Nationale des Caisses d' | ||
| * [[Unitaid]] | * [[Unitaid]] | ||
| Line 325: | Line 354: | ||
| * [[United Nations Industrial Development Organization]] (UNIDO) | * [[United Nations Industrial Development Organization]] (UNIDO) | ||
| * [[United Nations Institute for Training and Research]] (UNITAR) | * [[United Nations Institute for Training and Research]] (UNITAR) | ||
| + | * [[United Nations International Computing Centre]] (UNICC) | ||
| * [[United Nations Multidimensional Integrated Stabilization Mission in Mali]] | * [[United Nations Multidimensional Integrated Stabilization Mission in Mali]] | ||
| * [[United Nations Office for Project Services]] (UNOPS) | * [[United Nations Office for Project Services]] (UNOPS) | ||
| Line 335: | Line 365: | ||
| * [[United Nations Trust Fund for Human Security]] (UNTFHS) | * [[United Nations Trust Fund for Human Security]] (UNTFHS) | ||
| * [[United Nations University Institute for Global Health]] (UNU-IIGH) | * [[United Nations University Institute for Global Health]] (UNU-IIGH) | ||
| + | * [[United Nations University World Institute for Development Economics Research]] (UNU-WIDER) | ||
| * [[University College London]] (UCL) | * [[University College London]] (UCL) | ||
| * [[University of Antwerp]] | * [[University of Antwerp]] | ||
| Line 345: | Line 376: | ||
| * [[University of Exeter]] | * [[University of Exeter]] | ||
| * [[University of Lucerne]] | * [[University of Lucerne]] | ||
| + | * [[University of Natural Resources and Life Sciences, Vienna]] | ||
| * [[University of Newcastle]] | * [[University of Newcastle]] | ||
| * [[University of Oxford]] | * [[University of Oxford]] | ||
| Line 356: | Line 388: | ||
| * [[Vrije Universiteit Amsterdam]] | * [[Vrije Universiteit Amsterdam]] | ||
| * [[War Child Holland]] | * [[War Child Holland]] | ||
| + | * [[Wateraid America]] | ||
| * [[Wellcome Trust]] | * [[Wellcome Trust]] | ||
| * [[Wellspring Philanthropic Fund]] | * [[Wellspring Philanthropic Fund]] | ||
| Line 427: | Line 460: | ||
| Evaluation of ideas for potential platforms to support development and production of health technologies for priority infectious diseases with epidemic potential. | Evaluation of ideas for potential platforms to support development and production of health technologies for priority infectious diseases with epidemic potential. | ||
| - | After a brief overview of the WHO R&D Blueprint, information was provided on the [[: | + | After a brief overview of the WHO [[R&D Blueprint]], information was provided on the [[: |
| Epidemic Preparedness Innovation]] (CEPI); and following a summary of the public consultation process | Epidemic Preparedness Innovation]] (CEPI); and following a summary of the public consultation process | ||
| since its launch, the six finalists (3 vaccines, 1 diagnostics, | since its launch, the six finalists (3 vaccines, 1 diagnostics, | ||